Pfizer's future action may trigger Second Zuellig Problem.

Published: 2002-01-16 07:00:00

Updated: 2002-01-16 07:00:00

Recently Pfizer took part in a business association with Zuellig, which may cause another Zuellig problem in the pharmaceutical distribution industry since the Seoul Pharmaceutical Wholesale Association declared a harsh counter measure against Pfizer following the movement shown by Yungnam Pharm....

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK